HIGHLIGHTS
- who: Christopher E. Jensen from the Division of Hematology, University of North Carolina School of Medicine, Chapel Hill, NC, United States, Cecil GSheps have published the paper: Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis, in the Journal: (JOURNAL)
- what: Given the systemic nature of AL amyloidosis along with the inherent delay between initiation of therapy and end-organ response, effective supportive care is a critical component of overall management.
- how: The primary data supporting this approach derives from a trial in which pyridostigmine was utilized in combination . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.